Animal models of osteopetrosis: The impact of recent molecular developments on novel strategies for therapeutic intervention

Molecular Medicine Today

Volumn 2, Issue 8, 1996, Pages 349-358

  Popoff, Steven N ^a   Schneider, Gary B ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

COLONY STIMULATING FACTOR; MACROPHAGE ACTIVATING FACTOR; VITAMIN D BINDING PROTEIN;

ALBERS SCHOENBERG DISEASE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; MACROPHAGE ACTIVATION; MOUSE; ONCOGENE; ONCOGENE SRC; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; BONE RESORPTION; COLONY-STIMULATING FACTORS; DISEASE MODELS, ANIMAL; GENES, FOS; GENES, SRC; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGE-ACTIVATING FACTORS; MICE; MICE, TRANSGENIC; OSTEOCLASTS; OSTEOPETROSIS; VITAMIN D-BINDING PROTEIN;

EID: 0030210880     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)81801-6     Document Type: Review

References (39)

1. Seifert, M.F. et al. (1993) Experimental studies of osteopetrosis in laboratory animals, Clin. Orthop. Relat. Res. 294, 23-33
2. Marks, S.C., Jr (1989) Osteoclast biology: lessons from mammalian mutations, Am. J. Med. Genet. 34, 43-54
3. Teitelbaum, S.L., Coccia, P.F., Brown, D.M. and Kahn, A.J. (1981) Malignant osteopetrosis: a disease of abnormal osteoclast proliferation, Metab. Bone Dis. Relat. Res. 3, 99-105
4. Cournot, G. et al. (1992) Mineral metabolism in infants with malignant osteopetrosis: heterogeneity in plasma 1,25-dihydroxyvitamin D levels and bone histology, J. Bone Min. Res. 7, 1-10
5. Whyte, M.P. (1993) Carbonic anhydrase II deficiency, Clin. Orthop. Relat. Res. 294, 52-63
6. Golden, A. and Brugge, J.S. (1988) The src oncogene, in The Oncogene Handbook (Reddy, E.P., Skalka, A.M. and Curran, T., eds), pp. 149-173, Elsevier
7. Soriano, P., Montgomery, C., Geske, R. and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice, Cell 64, 693-702
8. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice, J. Clin. Invest. 90, 1622-1627
9. Boyce, B.F., Chen, H., Soriano, P. and Mundy, G.R. (1993) Histomorphometric and immunocytochemical studies of src-related osteopetrosis, Bone 14, 335-340
10. Lowe, C. et al. (1993) Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts, Proc. Natl. Acad. Sci. U.S.A. 90, 4485-4489
11. c-src in association with intracellular membranes, J. Cell Biol. 119, 1003-1013
12. c-src, preferentially on ruffled border membranes, Fed. Eur. Biochem. Soc. 313, 85-89
13. Hall, T.J., Schaeublin, M. and Missbach, M. (1994) Evidence that c-src is involved in the process of osteoclastic resorption, Biochem. Biophys. Res. Commun. 199, 1237-1244
14. Chiu, R. et al. (1988) The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes, J. Cell. Biochem. 56, 315-322
15. Grigoriadis, A.E., Wang, Z-Q. and Wagner, E.F. (1995) Fos and bone cell development: lessons from a nuclear oncogene, Trends Genet. 11, 436-441
16. Johnson, R.S., Spiegelman, B.M. and Papaioannou, V. (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene, Cell 71, 577-586
17. Wang, Z-Q. et al. (1992) Bone and hematopoietic defects in mice lacking c-fos, Nature 360, 741-745
18. Grigoriadis, A.E. et al. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling, Science 266, 443-448
19. Marks, S.C., Jr and Popoff, S.N. (1988) Bone cell biology: the regulation of development, structure, and function in the skeleton, Am. J. Anat. 183, 1-44
20. Felix, R., Cecchini, M.G. and Fleisch, H. (1990) Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse, Endocrinology 127, 2592-2594
21. Arceci, R.J., Pampfer, S. and Pollard, J.W. (1992) Role and expression of colony stimulating factor-1 and steel factor receptors and their ligands during pregnancy in the mouse, Reprod. Fertil. Dev. 4, 619-632
22. Felix, R. et al. (1990) Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic (op/op) mouse, J. Bone Min. Res. 5, 781-789
23. Yoshida, H. et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene, Nature 345, 442-444
24. Sundquist, K.T., Cecchini, M.G. and Marks, S.C., Jr (1995) CSF-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice, Bone 16, 39-46
25. Marks, S.C., Jr et al. (1993) The skeletal effects of colony-stimulating factor-1 in toothless (osteopetrotic) rats: persistent metaphyseal sclerosis and the failure to restore subepiphyseal osteoclasts, Bone 14, 675-680
26. Nilsson, S.K. et al. (1995) Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse, Blood 86, 66-72
27. Stanley, E. et al. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, Proc. Natl. Acad. Sci. U. S. A. 91, 5592-5596
28. Gowen, M. (1992) Cytokines and Bone Metabolism, CRC Press
29. Garrett, I.R. et al. (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo, J. Clin. Invest. 85, 632-639
30. Key, L.L., Jr, Ries, W.L., Rodriguiz, R.M. and Hatcher, H.C. (1992) Recombinant human Interferon γ therapy for osteopetrosis, J. Pediatr. 121, 119-124
31. Schneider, G.B. et al. (1995) Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations, Bone 16, 657-662
32. Key, L.L., Jr et al. (1995) Long-term treatment of osteopetrosis with recombinant human interferon γ, New Engl. J. Med. 332, 1594-1599
33. Hochman, N. et al. (1991) Reversal of immune dysfunction in osteopetrotic rats by interferon-γ. Augmentation of macrophage Ia expression and lymphocyte interleukin-2 production and proliferation, Cell. Immunol. 137, 14-23
34. Rodriguiz, R.M., Key, L.L., Jr and Ries, W.L. (1993) Combination macrophage-colony stimulating factor and interferon-γ administration ameliorates the osteopetrotic condition in microphthalmic (mi/mi) mice, Pediatr. Res. 33, 384-389
35. Cooke, N.E. and Haddad, J.G. (1995) Vitamin D binding protein (Gc globulin), in Hormonal Regulation of Bone Mineral Metabolism (Endocrine Review Monographs Vol. 4) (Bikle, D.D. and Negro-Vilar, A., eds), pp. 111-128, The Endocrine Society Press
36. 3 binding protein to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells, J. Immunol. 151, 2794-2802
37. 3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages, J. Immunol. 147, 273-280
38. Yamamoto, N. et al. (1994) A defect in the inflammation-primed activation cascade in osteopetrotic rats, J. Immunol. 152, 5100-5107
39. Popoff, S.N. and Schneider, G.B. (1994) Conversion of the vitamin D binding protein to a macrophage activating factor: associated defects in osteopetrotic mutations, in Vitamin D - a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications (Norman, A.W., Boullion, R. and Thomasset, M., eds), pp. 693-701, Walter DeGruyter